YOQNEAM, ISRAEL--(Marketwire - July 09, 2008) - Given Imaging Ltd. (NASDAQ: GIVN) (TELAVIV: GIVN) today announced a study published in the July issue of the Journal of Pediatric Gastroenterology and Nutrition found PillCam capsule endoscopy of the small bowel may enable more targeted and effective therapies for children with Crohn’s disease. According to the study, the opportunities for improved treatment regimens were a direct result of reclassifying inflammatory bowel disease (IBD) from ulcerative or indeterminate colitis to definitive Crohn’s disease and from uncovering a more significant burden of small bowel disease for those children already diagnosed with Crohn’s disease.
